Proportion of isolates with resistance to ciprofloxacin reported to in Singapore
Singapore: Proportion of isolates with resistance to ciprofloxacin reported to was 83.67 in 2018. ▲ Rising
Latest (2018)
83.67
Change on year
down 4.3%
World rank
12th
of 54 countries
All-time high
89.38
in 2014
All-time low
71.88
in 2012
Years of data
10
2009–2018
Proportion of isolates with resistance to ciprofloxacin reported to in Singapore, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
In 2018, proportion of isolates with resistance to ciprofloxacin reported to in Singapore stood at 83.67.
That represents a change of down 4.3% on the previous year and up 9.1% over ten years.
Over the whole period, proportion of isolates with resistance to ciprofloxacin reported to in Singapore peaked at 89.38 in 2014 and was at its lowest, 71.88, in 2012.
Singapore ranks 12th of 54 countries on this measure, in the top quarter.
Proportion of isolates with resistance to ciprofloxacin reported to in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 76.67 | — |
| 2010 | 74.38 | -3.0% |
| 2011 | 83.75 | +12.6% |
| 2012 | 71.88 | -14.2% |
| 2013 | 83.12 | +15.7% |
| 2014 | 89.38 | +7.5% |
| 2015 | 86.25 | -3.5% |
| 2016 | 81.88 | -5.1% |
| 2017 | 87.45 | +6.8% |
| 2018 | 83.67 | -4.3% |
Singapore compared with similar countries
- Singapore's 83.67 is above the median for high income countries, which is 55.25, 1.5× the median. (34 countries reporting)
- Singapore's 83.67 is above the median for East Asia & Pacific, which is 83.67, 1.0× the median. (13 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 76.67 | 76.67 | 76.67 | 1 |
| 2010s | 82.42 | 71.88 | 89.38 | 9 |
Countries ranked near Singapore
- 9 Korea 94.78 compare
- 10 Pakistan 93.75 compare
- 11 Brunei Darussalam 87.78 compare
- 13 Sri Lanka 83.33 compare
- 14 Côte d'Ivoire 80 compare
- 14 Philippines 80 compare
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.93 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0196 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in Singapore?
- Proportion of isolates with resistance to ciprofloxacin reported to in Singapore was 83.67 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in Singapore?
- The highest recorded value was 89.38 in 2014.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in Singapore?
- The lowest recorded value was 71.88 in 2012.
- How does Singapore rank for proportion of isolates with resistance to ciprofloxacin reported to?
- Singapore ranks 12th out of 54 countries with data for 2018.
- Is proportion of isolates with resistance to ciprofloxacin reported to rising or falling in Singapore?
- Over the last ten years it is up 9.1%. The long-run trend across the full record is rising.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).